Embla Medical hf. (OTCMKTS:OSSFF – Get Free Report) was the recipient of a large growth in short interest during the month of July. As of July 31st, there was short interest totaling 95 shares, a growth of ∞ from the July 15th total of 0 shares. Based on an average daily volume of 2 shares, the days-to-cover ratio is currently 47.5 days.
Embla Medical hf. Price Performance
Embla Medical hf. stock opened at $4.15 on Monday. Embla Medical hf. has a 12-month low of $4.15 and a 12-month high of $5.33. The firm’s 50-day moving average is $4.15 and its two-hundred day moving average is $4.34.
About Embla Medical hf.
Embla Medical hf., headquartered in Reykjavik, Iceland, develops and manufactures diagnostic medical devices for sleep, respiratory and neurophysiological monitoring. The company is publicly listed on Nasdaq Iceland and trades in the United States on the OTC market under the symbol OSSFF.
Embla Medical’s engineering and R&D teams design comprehensive solutions that combine hardware, sensors, electrodes and analysis software. Its portfolio includes ambulatory sleep assessment systems suitable for both in-lab and home-based polysomnography, as well as open-platform devices capable of capturing bioelectrical signals such as EEG, ECG and respiratory effort.
Beyond sleep diagnostics, the company’s technology supports respiratory care monitoring and neurophysiology research.
Featured Stories
- Five stocks we like better than Embla Medical hf.
- 3 ETFs Built to Protect Your Money if the Bull Market Breaks
- JFrog’s AI Opportunity Could Fuel a Big Leap in Share Price
- Is SiTime the Best AI Stock You’ve Never Heard Of?
- The Metals Company’s Big Bet Now Comes Down to a License
Receive News & Ratings for Embla Medical hf. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Embla Medical hf. and related companies with MarketBeat.com's FREE daily email newsletter.
